Zevra Therapeutics reported a gross margin of 96.16% and a net margin of 22.05% for the quarter ended Jun 2026. These financial ratios cover 50 quarters of results from Mar 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2014 | Jun2014 | Sep2014 | Dec2014 | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Gross Margin | 100.00% | 97.71% | 99.80% | 96.08% | 95.09% | 98.91% | 96.06% | 92.01% | 95.03% | 90.50% | 94.89% | 19.69% | 37.76% | 88.63% | 93.41% | 52.20% | 95.26% | 95.55% | 94.76% | 96.16% | ||||||||||||||||||||||||||||||
| EBT Margin | -89.52% | -103.37% | -47.11% | -1,904.38% | -231.35% | 319.93% | -419.40% | -31.25% | -351.99% | -153.96% | -487.36% | -446.28% | -897.97% | -169.56% | -9.40% | 296.93% | -3.74% | 37.08% | 123.70% | 32.23% | ||||||||||||||||||||||||||||||
| EBIT Margin | -113.08% | -110.07% | -46.89% | -1,905.15% | -230.55% | -460.58% | -404.00% | -73.81% | -530.71% | -117.31% | -598.13% | -534.84% | -738.00% | -128.34% | -26.28% | -274.28% | 15.87% | 27.27% | 143.97% | 42.26% | ||||||||||||||||||||||||||||||
| EBITDA Margin | -113.08% | -110.07% | -46.89% | -1,905.15% | -230.55% | -460.58% | -404.00% | -73.81% | -530.71% | -117.31% | -598.13% | -534.84% | -738.00% | -128.34% | -26.28% | -274.28% | 15.87% | 27.27% | 143.97% | 42.26% | ||||||||||||||||||||||||||||||
| Operating Margin | -113.08% | -110.07% | -46.89% | -1,905.15% | -230.55% | -460.58% | -404.00% | -73.81% | -530.71% | -117.31% | -598.13% | -534.84% | -738.00% | -128.34% | -26.28% | -274.28% | 15.87% | 27.27% | 143.97% | 42.26% | ||||||||||||||||||||||||||||||
| Net Margin | -89.52% | -104.69% | -47.01% | -1,849.38% | -230.20% | -446.14% | -370.50% | -30.38% | -358.10% | -153.96% | -485.31% | -447.85% | -897.97% | -297.53% | -15.19% | 288.44% | -2.08% | 35.62% | 104.61% | 22.05% | ||||||||||||||||||||||||||||||
| FCF Margin | -139.13% | -33.50% | -90.01% | -316.85% | -230.55% | -198.66% | -128.27% | -103.03% | -165.80% | -125.62% | -471.97% | -429.51% | -490.30% | -135.28% | -40.79% | -14.73% | 15.92% | 16.24% | 16.86% | 42.36% | ||||||||||||||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 2.26M | 1.83M | 1.24M | 1.55M | 2.02M | 2.38M | ||||||||||||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 137.99M | 135.06M | 129.32M | 124.98M | 121.90M | 117.45M | 110.97M | 106.06M | 122.25M | 155.65M | 161.81M | 147.85M | 167.98M | 184.84M | 175.42M | 214.49M | 263.20M | 277.42M | 281.65M | 290.65M | ||||||||||||||||||||||||||||||
| Invested CapitalInvested Cap. | 131.74M | 101.66M | 121.50M | 112.03M | 106.59M | 87.92M | 72.18M | 71.58M | 100.32M | 104.63M | 86.76M | 90.81M | 128.67M | 99.17M | 101.11M | 177.92M | 194.47M | 216.59M | 205.80M | 217.65M | ||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.21 | 0.21 | 0.16 | 0.08 | 0.09 | 0.09 | 0.08 | 0.16 | 0.14 | 0.18 | 0.17 | 0.16 | 0.15 | 0.13 | 0.23 | 0.29 | 0.32 | 0.38 | 0.43 | 0.47 | ||||||||||||||||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -370.33 | -568.40 | -371.80 | -687.97 | -53.44 | -54.78 | -70.50 | -31.74 | -41.98 | -20.05 | -27.87 | -11.28 | -11.81 | -7.03 | -2.72 | -35.36 | 2.02 | 4.78 | 30.48 | |||||||||||||||||||||||||||||||
| Debt Ratio | 0.10 | 0.11 | 0.11 | 0.12 | 0.12 | 0.28 | 0.25 | 0.25 | 0.40 | 0.31 | 0.33 | 0.35 | 0.24 | 0.23 | 0.22 | |||||||||||||||||||||||||||||||||||
| Times Interest Earned | -370.33 | -568.40 | -371.80 | -687.97 | -53.44 | -54.78 | -70.50 | -31.74 | -41.98 | -20.05 | -27.87 | -11.28 | -11.81 | -7.03 | -2.72 | -35.36 | 2.02 | 4.78 | 30.48 | |||||||||||||||||||||||||||||||
| Valuation | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -374.66 | -225.60 | -185.78 | -12.80 | -65.08 | -17.57 | -15.84 | -67.25 | -16.84 | -13.68 | -14.60 | -10.33 | -11.12 | -12.52 | -132.16 | 6.50 | -982.78 | 41.88 | 14.54 | 97.23 | ||||||||||||||||||||||||||||||
| Price to SalesP/S | 335.38 | 236.17 | 87.34 | 236.65 | 149.82 | 78.41 | 58.67 | 20.43 | 60.29 | 21.06 | 70.87 | 46.25 | 99.84 | 37.26 | 20.07 | 18.74 | 20.48 | 14.91 | 15.21 | 21.43 | ||||||||||||||||||||||||||||||
| Price to BookP/B | 5.00 | 6.00 | 2.85 | 3.10 | 4.59 | 2.11 | 3.14 | 2.94 | 2.84 | 4.40 | 4.97 | 6.34 | 5.29 | 11.28 | 9.98 | 4.14 | 4.01 | 3.29 | 2.68 | 3.91 | ||||||||||||||||||||||||||||||
| Enterprise Value | 527.52M | 497.45M | 244.72M | 226.67M | 354.68M | 76.17M | 111.77M | 86.14M | 91.60M | 204.32M | 190.02M | 156.50M | 280.02M | 378.12M | 346.92M | 282.68M | 335.12M | 318.41M | 350.33M | 629.39M | ||||||||||||||||||||||||||||||
| EV to EBIT | -237.41 | -175.04 | -131.64 | -9.15 | -53.53 | -8.18 | -8.71 | -13.78 | -5.96 | -13.48 | -9.28 | -6.58 | -10.25 | -24.53 | -64.70 | -3.98 | 80.89 | 34.18 | 6.72 | 37.52 | ||||||||||||||||||||||||||||||
| EV to EBITDA | -237.41 | -175.04 | -131.64 | -9.15 | -53.53 | -8.18 | -8.71 | -13.78 | -5.96 | -13.48 | -9.28 | -6.58 | -10.25 | -24.53 | -64.70 | -3.98 | 80.89 | 34.18 | 6.72 | 37.52 | ||||||||||||||||||||||||||||||
| Market Capitalization | 659.02M | 609.80M | 346.30M | 307.64M | 430.57M | 158.54M | 186.35M | 173.03M | 174.54M | 272.05M | 242.73M | 205.76M | 369.40M | 447.61M | 409.55M | 485.29M | 534.63M | 509.42M | 550.95M | 850.96M | ||||||||||||||||||||||||||||||
| Price to FCFP/FCF | -241.05 | -704.97 | -97.03 | -74.69 | -64.98 | -39.47 | -45.74 | -19.83 | -36.36 | -16.76 | -15.02 | -10.77 | -20.36 | -27.55 | -49.22 | -127.24 | 128.67 | 91.84 | 90.22 | 50.61 | ||||||||||||||||||||||||||||||
| EV to FCF | -192.95 | -575.09 | -68.57 | -55.03 | -53.53 | -18.96 | -27.43 | -9.87 | -19.08 | -12.59 | -11.75 | -8.19 | -15.44 | -23.27 | -41.69 | -74.12 | 80.66 | 57.40 | 57.37 | 37.43 | ||||||||||||||||||||||||||||||
| EV to CFO | -193.23 | -586.62 | -68.88 | -55.23 | -53.76 | -17.07 | -27.63 | -9.90 | -19.79 | -12.64 | -11.75 | -8.19 | -15.44 | -23.27 | -42.19 | -78.50 | 71.17 | 57.72 | 57.04 | 36.95 | ||||||||||||||||||||||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -113.08% | -110.07% | -46.89% | -1,905.15% | -230.55% | -460.58% | -404.00% | -73.81% | -530.71% | -117.31% | -598.13% | -534.84% | -738.00% | -128.34% | -26.28% | -274.28% | 15.87% | 27.27% | 143.97% | 42.26% | ||||||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | 5.48% | 5.91% | -0.86% | -26.90% | -31.81% | -40.38% | -56.15% | -39.89% | -43.53% | -60.54% | -43.41% | -63.72% | -64.98% | -57.70% | -48.42% | -64.16% | -36.98% | -26.43% | -2.32% | 34.04% | ||||||||||||||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | 6.65% | -1.29% | -26.54% | -32.36% | -43.71% | -66.65% | -50.26% | -52.77% | -59.88% | -84.48% | -89.39% | -87.61% | -10.55% | -31.01% | -29.41% | -2.40% | 32.72% | |||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -7.76% | -6.33% | -0.10% | -24.30% | -28.90% | -22.80% | -34.36% | -15.70% | -16.69% | -29.58% | -30.56% | -45.19% | -53.38% | -57.08% | -52.44% | 1.23% | 13.42% | 30.00% | 44.10% | 20.05% |